Photo from wikipedia
Key Points G-CSF is an effective long-term therapy for SCN with a wide range of effective doses requiring individualized dose titration. Eleven percent of patients with CN developed MDS/AML; patients… Click to show full abstract
Key Points G-CSF is an effective long-term therapy for SCN with a wide range of effective doses requiring individualized dose titration. Eleven percent of patients with CN developed MDS/AML; patients with autoimmune/idiopathic neutropenia did not develop myeloid leukemia.
Keywords:
outcomes patients;
severe chronic;
chronic neutropenia;
patients severe;
neutropenia treated;
neutropenia
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!